These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 33153990)

  • 41. Pulmonary Rehabilitation for Exercise Tolerance and Quality of Life in IPF Patients: A Systematic Review and Meta-Analysis.
    Yu X; Li X; Wang L; Liu R; Xie Y; Li S; Li J
    Biomed Res Int; 2019; 2019():8498603. PubMed ID: 31016200
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Depression Is Significantly Associated with the Health Status in Patients with Idiopathic Pulmonary Fibrosis.
    Matsuda T; Taniguchi H; Ando M; Kondoh Y; Kimura T; Kataoka K; Nishimura K; Nishiyama O; Sakamoto K; Hasegawa Y
    Intern Med; 2017; 56(13):1637-1644. PubMed ID: 28674350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psychometric properties of patient reported outcome measures in idiopathic pulmonary fibrosis.
    Kim JW; Clark A; Birring SS; Atkins C; Whyte M; Wilson AM
    Chron Respir Dis; 2021; 18():14799731211033925. PubMed ID: 34609156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Are idiopathic pulmonary fibrosis patients more anxious and depressive than patient's with other interstitial lung disease?
    Yalnız E; Polat G; Demirci F; Deniz S; Karadeniz G; Aydınlı E; Vayisoglu G; Ayrancı A
    Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(4):294-301. PubMed ID: 32476965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in quality of life and functional capacity after lung transplantation: A single-center experience.
    Ricotti S; Martinelli V; Caspani P; Monteleone S; Petrucci L; Dalla Toffola E; Klersy C
    Monaldi Arch Chest Dis; 2017 Dec; 87(3):831. PubMed ID: 29424193
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Psychometric properties of the St George's Respiratory Questionnaire in patients with idiopathic pulmonary fibrosis: insights from the INPULSIS trials.
    Swigris JJ; Wilson H; Esser D; Conoscenti CS; Stansen W; Kline Leidy N; Brown KK
    BMJ Open Respir Res; 2018; 5(1):e000278. PubMed ID: 29862029
    [TBL] [Abstract][Full Text] [Related]  

  • 47. COPD Assessment Test for measurement of health status in patients with idiopathic pulmonary fibrosis: A cross-sectional study.
    Matsuda T; Taniguchi H; Ando M; Kondoh Y; Kimura T; Kataoka K; Sakamoto K; Suzuki A; Furukawa T; Hasegawa Y
    Respirology; 2017 May; 22(4):721-727. PubMed ID: 27859913
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Psychometrics of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysis.
    McLeese RH; Spinou A; Alfahl Z; Tsagris M; Elborn JS; Chalmers JD; De Soyza A; Loebinger MR; Birring SS; Fragkos KC; Wilson R; O'Neill K; Bradley JM
    Eur Respir J; 2021 Nov; 58(5):. PubMed ID: 33888521
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of physical and mental health-related quality of life in patients with interstitial lung disease: a multifactorial analysis.
    Coelho AC; Knorst MM; Gazzana MB; Barreto SS
    J Bras Pneumol; 2010; 36(5):562-70. PubMed ID: 21085821
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term effects of a 12-week exercise training program on clinical outcomes in idiopathic pulmonary fibrosis.
    Vainshelboim B; Oliveira J; Fox BD; Soreck Y; Fruchter O; Kramer MR
    Lung; 2015 Jun; 193(3):345-54. PubMed ID: 25731736
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis. A Randomized Controlled Trial.
    Moor CC; Mostard RLM; Grutters JC; Bresser P; Aerts JGJV; Chavannes NH; Wijsenbeek MS
    Am J Respir Crit Care Med; 2020 Aug; 202(3):393-401. PubMed ID: 32325005
    [No Abstract]   [Full Text] [Related]  

  • 52. Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis. Data from the IPF-PRO Registry.
    Salisbury ML; Conoscenti CS; Culver DA; Yow E; Neely ML; Bender S; Hartmann N; Palmer SM; Leonard TB;
    Ann Am Thorac Soc; 2020 Nov; 17(11):1413-1423. PubMed ID: 32574517
    [No Abstract]   [Full Text] [Related]  

  • 53. Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.
    McCabe C; McCann M; Brady AM
    Cochrane Database Syst Rev; 2017 May; 5(5):CD011425. PubMed ID: 28535331
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial.
    Visca D; Tsipouri V; Mori L; Firouzi A; Fleming S; Farquhar M; Leung E; Maher TM; Cullinan P; Hopkinson N; Wells AU; Banya W; Whitty JA; Adamali H; Spencer LG; Sestini P; Renzoni EA
    Trials; 2017 Apr; 18(1):201. PubMed ID: 28454553
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SF36 Is a Reliable Patient-Oriented Outcome Evaluation Tool in Surgically Treated Degenerative Cervical Myelopathy Cases: A Systematic Review and Meta-Analysis.
    Wang WG; Dong LM; Li SW
    Med Sci Monit; 2019 Sep; 25():7126-7137. PubMed ID: 31542788
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlations between disease-specific and generic health status questionnaires in patients with advanced COPD: a one-year observational study.
    Wilke S; Janssen DJ; Wouters EF; Schols JM; Franssen FM; Spruit MA
    Health Qual Life Outcomes; 2012 Aug; 10():98. PubMed ID: 22909154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation of the Cough Quality-of-Life Questionnaire in patients with idiopathic pulmonary fibrosis.
    Lechtzin N; Hilliard ME; Horton MR
    Chest; 2013 Jun; 143(6):1745-1749. PubMed ID: 23519393
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival and quality of life in rheumatoid arthritis-associated interstitial lung disease after lung transplantation.
    Yazdani A; Singer LG; Strand V; Gelber AC; Williams L; Mittoo S
    J Heart Lung Transplant; 2014 May; 33(5):514-20. PubMed ID: 24630861
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry.
    Wuyts WA; Dahlqvist C; Slabbynck H; Schlesser M; Gusbin N; Compere C; Maddens S; Rizzo S; Kirchgaessler KU; Bartley K; Bondue B
    Pulm Ther; 2022 Jun; 8(2):181-194. PubMed ID: 35429319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Usefulness of a linear analog scale questionnaire to measure health-related quality of life in elderly patients with chronic obstructive pulmonary disease.
    Katsura H; Yamada K; Kida K
    J Am Geriatr Soc; 2003 Aug; 51(8):1131-5. PubMed ID: 12890078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.